17:02 EDT Outlook Therapeutics (OTLK) files to sell 21.72M shares of common stock for holders
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OTLK:
- Outlook Therapeutics management to meet virtually with BTIG
- Outlook Therapeutics Issues Convertible Note to Avondale
- Outlook Therapeutics files to sell 7.07M shares of common stock for holders
- Outlook Therapeutics re-submits BLA to U.S. FDA for ONS-5010
- Outlook Therapeutics price target lowered to $10 from $12 at Guggenheim